What did ArchiMed Group pay for Natus Medical?

ArchiMed Group acquired Natus Medical for $1.20B in 2022 (23.1x EBITDA), equivalent to 2.50x revenue. Target revenue was approximately $478.0M. Target EBITDA was approximately $52.0M.

What does Natus Medical do?

Natus Medical is a medical devices business.

What multiple did ArchiMed Group pay for Natus Medical?

23.1x EBITDA and 2.50x revenue, based on disclosed deal value of $1.20B and disclosed financials.

M&A TRANSACTION · 2022

Natus Medical acquired by ArchiMed Group

$1.20B· 23.1x EBITDA· 2.50x revenue

Target

Natus Medical

Acquirer

ArchiMed Group

Disclosed financials at time of acquisition

Revenue

$478.0M

EBITDA

$52.0M

Deal Value

$1.20B

EV/EBITDA

23.1x

Context

This $1.20B acquisition of Natus Medical by ArchiMed Group sits in the medical devices sub-vertical. The 23.1x EBITDA multiple paid in 2022 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub.

Source

Data sourced from Press releases and fairness opinion. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Natus Medical acquisition.

Citation: ExitValue.ai. (2022). Natus Medical acquired by ArchiMed Group. https://exitvalue.ai/deals/natus-medical-acquired-by-archimed-group-hc-2022-0063